RxNorm Semantic Concepts Index - 536
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "536".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 5360 | Histone kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5360 | Histone kinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5360 | Histone kinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 53616 | Chloroprocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 53616 | Chloroprocaine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 53616 | Chloroprocaine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 5363 | histoplasmin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 53654 | Nevirapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 53654 | Nevirapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 53654 | Nevirapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 53654 | Nevirapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 53654 | Nevirapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 5367 | HIV - Human immunodeficiency virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5367 | HIV - Human immunodeficiency virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5367 | HIV - Human immunodeficiency virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5367 | HIV - Human immunodeficiency virus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5367 | HIV - Human immunodeficiency virus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 53674 | Nicotinate-nucleotide-dimethylbenz-imidazole phosphoribosyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 53674 | Nicotinate-nucleotide-dimethylbenz-imidazole phosphoribosyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 53692 | nilvadipine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 53692 | nilvadipine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 53692 | nilvadipine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 53694 | nimesulide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 53694 | nimesulide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 53694 | nimesulide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 53694 | nimesulide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 53694 | nimesulide | Full form of descriptor (FN) | NO |